KR20000038444A - Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides - Google Patents
Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides Download PDFInfo
- Publication number
- KR20000038444A KR20000038444A KR1019980053457A KR19980053457A KR20000038444A KR 20000038444 A KR20000038444 A KR 20000038444A KR 1019980053457 A KR1019980053457 A KR 1019980053457A KR 19980053457 A KR19980053457 A KR 19980053457A KR 20000038444 A KR20000038444 A KR 20000038444A
- Authority
- KR
- South Korea
- Prior art keywords
- kimchi
- fatty acid
- pufa
- polyunsaturated fatty
- added
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/10—Preserving with acids; Acid fermentation
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- General Preparation And Processing Of Foods (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 다당류물질로 미세캡슐화된 식품첨가용 ω3계 고도 불포화지방산을 제조하여 이를 첨가한 김치 및 그 제조방법에 관한 것으로, 좀 더 상세하게는 체내 콜레스테롤 함량 강화 작용이 우수한 ω3계 고도 불포화지방산을 용해시킨 지방질 용액을 식품유화제 및 다당류 물질이 함유되어 있는 수용액에 첨가시켜 고도 불포화지방산이 다당류 물질에 의하여 둘러쌓인 형태인 수중 유적형 유화액(oil in water emulsion system)을 제조한 후, 상기 방법으로 제조된 수중 유적형 유화용액을 김치제품에 첨가하여 다당류 물질로 미세캡슐화된 ω3계 고도 불포화지방산을 김치제품내에 균일하게 분포시킴으로써 고도 불포화지방산의 저장중 발생될 수 있는 변패의 예방 및 체내에서의 콜레스테롤 함량 저하작용을 극대화시킬 수 있는 미세캡슐화된 ω3계 고도 불포화지방산이 첨가된 김치 및 그 제조방법에 관한 것이다.The present invention relates to a kimchi prepared by adding a ω3-based polyunsaturated fatty acid microencapsulated with a polysaccharide material, and to a method of producing the same. The dissolved fat solution is added to an aqueous solution containing a food emulsifier and a polysaccharide material to prepare an oil in water emulsion system in which the polyunsaturated fatty acid is surrounded by the polysaccharide material, and then prepared by the above method. By adding the oil-in-water emulsified solution to the kimchi product, the ω3-based polyunsaturated fatty acid microencapsulated with polysaccharide material is uniformly distributed in the kimchi product to prevent the deterioration that may occur during the storage of the polyunsaturated fatty acid and the cholesterol content in the body. Microencapsulated ω3-based altitude defects to maximize degradation The fatty acid is added kimchi and relates to a method of manufacturing the same.
종래 인체유익한 기능을 갖는 김치의 제조방법은 체내에서 유익한 ω3계 고도 불포화지방산 용액을 직접적으로 투입하되, 위장을 경유할 때의 낮은 수소이온 농도(pH 1.8 ∼ 2.0) 및 고농도의 염산에 의하여 변질되어 소실되는 고도 불포화지방산의 함량을 고려하여 초기에 첨가시키는 고도 불포화지방산의 농도를 고농도로 유지시킴으로서 혈관내에서의 콜레스테롤 함량 저하 작용이 가능하도록 하는 방법을 사용하여 왔다. 그러나 이러한 직접적인 투입 방법을 사용할 경우, 초기에 첨가하는 고도불포화지방산의 농도가 매우 높기 때문에 식품위생법상의 큰 제약이 수반되며 또한 일정 농도로 고도불포화지방산의 함량을 높일 수 있다 할지라도 위장을 통과하면서 극단적인 수소이온 농도(pH 1.8 ∼ 2.0)에 의하여 변질되어 소실되는 고도 불포화지방산의 함량이 너무 많기 때문에 경제적인 측면에서 고려해 볼때에도 비효율적이어서 그 사용이 제한되어 왔다.Conventionally, the method of preparing kimchi having a beneficial effect on human body is directly injected into the body with beneficial ω3-based polyunsaturated fatty acid solution, but is deteriorated by low hydrogen ion concentration (pH 1.8 to 2.0) and high concentration of hydrochloric acid when gastrointestinal is passed. Considering the amount of polyunsaturated fatty acids lost, a method of lowering cholesterol content in blood vessels has been used by maintaining a high concentration of polyunsaturated fatty acids initially added at high concentrations. However, the direct dosing method is very high in the concentration of polyunsaturated fatty acids added initially, which entails significant limitations in the food hygiene law, and even if it is possible to increase the content of polyunsaturated fatty acids at a certain concentration, it is extremely difficult to pass through the stomach. Since the content of polyunsaturated fatty acids, which are deteriorated and lost due to phosphorus ion concentration (pH 1.8 to 2.0), is too inefficient in terms of economics, its use has been limited.
근래에는 이러한 상기 단점을 극복하기 위하여 각종 피복제를 사용하여 고도 불포화지방산을 코팅시키는 방법에 의한 거대 캡슐화 기술을 도입함으로서 신선한 고도 불포화지방산의 함량을 증가시키는 방법이 시도되고 있다. 그러나 이러한 방법을 사용하는 경우 일정 수준까지 체내에 신선한 고도 불포화지방산의 농도를 높일 수 있는 장점은 있지만 음용상의 간편성, 피복물질(캡슐)의 가공적성 및 피복물질의 용해성이라는 측면에서 아직도 개선되어야 할 점이 매우 많이 남아있다. 즉, 거대캡슐(폭 0.5 ∼ 1 cm, 길이 1 ∼ 3 cm, 캡슐두께 0.5 ∼ 1 mm)에 의하여 피복된 고도 불포화지방산 정(錠)은 유아, 어린이 및 노인과 같은 노약자들이 복용하기에는 매우 어려우며 상기 거대 캡슐을 가공하기 위한 부대시설 및 기술이 투여됨으로서 경제적인 측면에서 매우 불리한 단점이 있었다.Recently, in order to overcome this drawback, a method of increasing the content of fresh polyunsaturated fatty acids by introducing a large encapsulation technique by coating polyunsaturated fatty acids using various coating agents has been attempted. However, this method has the advantage of increasing the concentration of fresh polyunsaturated fatty acids in the body to a certain level, but still needs to be improved in terms of ease of drinking, processability of the coating material (capsules) and solubility of the coating material. Very much remains. That is, polyunsaturated fatty acid tablets coated by large capsules (0.5-1 cm in width, 1-3 cm in length, 0.5-1 mm in capsule thickness) are very difficult for the elderly, such as infants, children and the elderly to take. The administration of facilities and techniques for processing large capsules has been very disadvantageous in terms of economics.
또한 거대 캡슐에 의해 코팅되어 안전하게 위장을 통과한 고도 불포화지방산 캡슐의 피복제는 췌장 및 소장에서 분비되는 효소에 의하여 분해되어야만 하는데 거대 캡슐의 피복제 두께는 0.5 ∼ 1 mm 로 매우 단단하며 두꺼운 조직이므로 잘 분해되지 않아 체내에서 고도 불포화지방산의 장점을 충분히 활용하지 못하는 큰 결점이 있었다.In addition, the coating of the polyunsaturated fatty acid capsule coated by the large capsule and safely passed through the stomach should be decomposed by enzymes secreted from the pancreas and small intestine. The coating thickness of the large capsule is 0.5-1 mm, which is very hard and thick tissue. There was a big drawback that it did not decompose well and could not take full advantage of polyunsaturated fatty acid in the body.
본 발명의 목적은 상기와 같은 결점을 감안하여 안출한 것으로 다당류 물질로 미세캡슐화된 식품첨가용 ω3계 고도 불포화지방산을 제조하여 김치에 첨가함으로써 미세캡슐화된 ω3계 고도 불포화지방산 함유 김치를 제공함에 있다.An object of the present invention is to provide a kimchi containing ω3-based polyunsaturated fatty acid microencapsulated by preparing a ω3-based polyunsaturated fatty acid for food additives microencapsulated with a polysaccharide material and added to kimchi in view of the above drawbacks. .
상기 목적을 달성하기 위한 본 발명은 다당류물질이 소정의 농도로 분산·함유된 수용액에 식품유화제를 소정의 농도로 혼합하고, 가열·살균한 후 40 ∼50℃로 유지시켜 투명한 수용액을 제조하는 단계와, 상기 단계에서 수용액에 고도불포화지방산을 용해시킨 지방질용액을 첨가시켜 균질기로 혼합시켜 유화액을 제조하는 단계와, 상기 단계의 유화액을 5 ∼ 20℃의 물에 고압분무시켜 미세캡슐이 함유된 현탁액을 제조하는 단계와, 상기 단계에서 제조된 ω3계 고도 불포화지방산 미세캡슐용액을 김치에 첨가하여 10℃이하의 온도범위에서 저장하는 단계로 이루어짐을 특징으로 한다.The present invention for achieving the above object is to prepare a transparent aqueous solution by mixing the food emulsifier to a predetermined concentration in an aqueous solution in which the polysaccharide material is dispersed and contained at a predetermined concentration, and then heated and sterilized to maintain a 40 ~ 50 ℃ And, in the step of adding an aliphatic solution in which the polyunsaturated fatty acid is dissolved in an aqueous solution in a homogeneous mixture to prepare an emulsion, and the emulsion of the above step by high-pressure spraying in water of 5 ~ 20 ℃ fine suspension containing capsules To prepare a step, and by adding the ω3-based polyunsaturated fatty acid microcapsule solution prepared in the step to kimchi and storing in a temperature range of 10 ℃ or less.
이하 본 발명을 좀 더 구체적으로 살펴보면 다음과 같다.Looking at the present invention in more detail as follows.
본 발명에서는 체내 콜레스테롤 함량 강하작용이 뛰어난 ω3계 고도 불포화지방산[Kazumasa, P. (1991) Journal of Japanese Oil Chemical Society 37, 9-13] 을 용해시킨 지방질 용액을 식품유화제 및 다당류물질이 함유되어 있는 수용액 속에서 ω3계 고도 불포화지방산이 다당류물질에 의하여 둘러쌓여 있는 형태인 수중유적형 유화액을 제조한 후, 5 ∼ 20℃ 물에 수중유적형 유화용액을 고압·분무시켜 다당류물질로 미세캡슐화된 ω3계 고도불포화지방산을 제조하여 김치속에 1 ∼ 1000 mg%(w/w)의 농도로 균일하게 첨가함으로써 체내의 소화과정중 극단적인 외부환경(위액의 pH = 1.8 ∼ 2.0)과 격리시키고 동시에 캡슐내부에서는 체내에서의 콜레스테롤 함량 저하작용에 유익한 ω3계 고도불포화지방산이 변질되지 않고 신선한 상태로 유지된 후, 췌장 및 소장을 경유하면서 체내분비 효소에 의하여 피복물질인 다당류가 분해되어 미세캡슐 내부의 신선한 ω3계 고도불포화지방산이 유출되게 하여 체내에서의 콜레스테롤 함량 저하작용의 효과를 극대화시킬 수 있도록 하였다.In the present invention, a fat solution containing ω3-based polyunsaturated fatty acid [Kazumasa, P. (1991) Journal of Japanese Oil Chemical Society 37, 9-13], which has excellent cholesterol lowering content, contains food emulsifiers and polysaccharides. Ω3 microencapsulated ω3 by polysaccharides was prepared by preparing an oil-in-water emulsion in which the ω3-based polyunsaturated fatty acid is surrounded by a polysaccharide in an aqueous solution. By preparing a highly unsaturated fatty acid in the kimchi and adding it uniformly to the concentration of 1 ~ 1000 mg% (w / w), it is isolated from the extreme external environment (pH of gastric juice = 1.8 ~ 2.0) during digestion of the body and at the same time inside the capsule In the ω3 polyunsaturated fatty acid, which is beneficial for lowering cholesterol content in the body, remains fresh without deterioration, and then passes through the pancreas and small intestine. The polysaccharide, which is a coating material, was decomposed by the secretory enzyme, and the fresh ω3-type polyunsaturated fatty acid in the microcapsules was spilled to maximize the effect of lowering cholesterol content in the body.
본 발명에 사용되는 불포화지방산으로는 DHA, EPA, 감마-리놀렌산, 아라키돈산 등이다.Unsaturated fatty acids used in the present invention include DHA, EPA, gamma-linolenic acid, arachidonic acid and the like.
이하, 본 발명의 김치와 그 제조방법을 공정별로 더욱 구체적으로 설명하면 다음과 같다.Hereinafter, the kimchi of the present invention and a manufacturing method thereof will be described in more detail by process.
제 1 공정: ω3계 고도불포화지방산의 미세캡슐화를 위한 코팅물질의 제조First step: preparation of coating material for microencapsulation of ω3-based polyunsaturated fatty acids
찹쌀전분, 찰옥수수전분, 아가 등 다당류물질 단독 또는 2종류 이상 혼합물이 0.2 ∼ 4.0%(w/v)의 농도로 분산되어있는 수용액내에 HLB(hydrophilic lipophilic balance)가 8 ∼ 18의 값을 갖는 식품유화제를 0.5 ∼ 3.0%(w/v)의 농도로 첨가시킨 전체수용액을 가열·살균한 후, 40 ∼ 50℃로 유지시킴으로서 투명한 수용액을 제조하였다.Foods with a HLB (hydrophilic lipophilic balance) value of 8-18 in an aqueous solution in which a polysaccharide substance alone or a mixture of two or more kinds such as glutinous rice starch, waxy corn starch and agar is dispersed at a concentration of 0.2 to 4.0% (w / v) After the whole aqueous solution which added the emulsifier to the density | concentration of 0.5-3.0% (w / v) was heated and sterilized, it maintained at 40-50 degreeC, and the transparent aqueous solution was produced.
이때 사용가능한 식품유화제로는 트윈 20, 60, 80 (tween 20, 60, 80), 스팬 60, 80 (span 60, 80) 및 솔비탄 지방산 에스테르 (sorbitan fatty acid ester) 등이 바람직하다. 또한, 다당류물질은 예를들어 찹쌀전분, 찰옥수전분, agar 등과 같은 것으로서 50 ∼ 60℃에서 액화될 수 있는 것이 바람직하다.At this time, the food emulsifiers that can be used are tween 20, 60, 80 (tween 20, 60, 80), span 60, 80 (span 60, 80) and sorbitan fatty acid ester (sorbitan fatty acid ester). In addition, the polysaccharide material is, for example, glutinous rice starch, waxy corn starch, agar, etc., it is preferable that it can be liquefied at 50 ~ 60 ℃.
제 2 공정: ω3계 고도불포화지방산의 미세캡슐화를 위한 유화액의 제조Second Process: Preparation of Emulsion for Microencapsulation of ω3-based Polyunsaturated Fatty Acids
상기 제 1 공정에서 제조된 40 ∼ 50℃의 코팅제 용액내에 미세캡슐화시킬 ω3계 고도불포화지방산 용액을 40 ∼ 60%(w/w)의 농도로 첨가시킨 후, 강력한 혼합기를 사용하여 균질의 유화액을 제조한다.After adding the ω3-based polyunsaturated fatty acid solution to be microencapsulated in the coating solution prepared at the first step of 40-50 ° C. at a concentration of 40-60% (w / w), a homogeneous emulsion was used using a powerful mixer. Manufacture.
제 3 공정: ω3계 고도불포화지방산의 미세캡슐화Third Step: Microencapsulation of ω3-based Polyunsaturated Fatty Acids
상기 제 2공정에서 제조한 유화액을 고압분무기를 이용하여 5 ∼ 20℃의 물에 직접 분무시켜 다당류물질로 미세캡슐화된 ω3계 고도불포화지방산을 함유하고 있는 현탁액을 제조한다.The emulsion prepared in the second step is directly sprayed into water at 5 to 20 ° C. using a high pressure atomizer to prepare a suspension containing ω3-based polyunsaturated fatty acid microencapsulated with a polysaccharide material.
제 4 공정: 미세캡슐화된 ω3계 고도불포화지방산이 함유된 김치제품의 완성Fourth Step: Completion of Kimchi Product Containing Microencapsulated ω3 Polyunsaturated Fatty Acid
상기 제 3 공정에서 제조한 미세캡슐 함유 현탁액을 0 ∼ 4℃로 유지되는 곳에서 김치((주)아진식품 (경상북도 경산시))에 미세캡슐화된 ω3계 고도불포화지방산이 1 ∼ 1000 mg%(w/w)의 농도가 되도록 첨가하여 제품을 완성하였다.1 to 1000 mg% of ω3-based polyunsaturated fatty acids microencapsulated in kimchi (Ajin Food Co., Ltd. (Gyeongsan, Gyeongsangbuk-do)) where the microcapsule-containing suspension prepared in the third step is maintained at 0 to 4 ° C. / w) was added to complete the product.
본 발명의 방법에 의하여 제조된 다당류물질로 미세캡슐화된 ω3계 고도불포화지방산이 함유된 김치는 일반 김치제품과 유사한 성상 및 특성을 지니면서 체내에서의 콜레스테롤 함량 저하작용을 갖는 효과가 있는 것으로 나타났다.Kimchi containing ω3-based polyunsaturated fatty acids microencapsulated with the polysaccharide material prepared by the method of the present invention was shown to have an effect of lowering cholesterol content in the body while having similar properties and properties as general kimchi products.
이하, 바람직한 실시예를 통하여 본 발명 다당류물질로 미세캡슐화된 ω3계 고도 불포화지방산 함유 김치를 제조하는 방법에 대하여 좀더 구체적으로 설명한다.Hereinafter, a method for producing ω3-based polyunsaturated fatty acid-containing kimchi finely encapsulated with the present invention a polysaccharide through a preferred embodiment will be described in more detail.
그러나 하기의 실시예가 본 발명의 기술적 범위를 제한하는 것은 아니며, 본 발명의 실시예의 한 태양을 제시하고자 함이다.However, the following examples are not intended to limit the technical scope of the present invention, but are intended to present an aspect of the embodiments of the present invention.
실시예 1Example 1
찰옥수수전분과 아가(agar)가 각각 0.25%(w/v)의 농도로 분산·용해되어 있는 수용액내에 친수성 유화제인 솔비탄모노라우르산(sorbitan monolaurate, 미국, 시그마(Sigma)社)을 2%(w/v)되게 첨가시켜 전체 수용액을 가열살균시킨 후, 40 ∼ 50℃로 유지되는 항온실에서 보관한 다음, 상기 수용액 500 g에 DHA(docosahexaenoic acid) 용액 500 g을 첨가시킨 후, 혼합기를 사용하여 균질의 유화액을 제조한 다음, 상기 유화액을 5 ∼ 20℃의 멸균수 10 L에 직접 고압분무시켜 다당류물질로 미세캡슐화된 DHA용액을 함유한 현탁액을 제조하고, 상기 미세캡슐 용액을 김치제품에 첨가하되 미세캡슐화된 DHA가 1 ∼ 1,000 mg%(w/w)의 농도가 되도록 조절하여 최종제품을 완성하였다.Sorbant monolaurate (Sigma, USA), a hydrophilic emulsifier, was dissolved in an aqueous solution in which waxy starch and agar were dispersed and dissolved at a concentration of 0.25% (w / v), respectively. % (w / v) was added to heat sterilize the whole aqueous solution, and then stored in a constant temperature room maintained at 40-50 ° C., 500 g of the aqueous solution of DHA (docosahexaenoic acid) was added to the mixer, followed by a mixer. Using to prepare a homogeneous emulsion, and then directly spraying the emulsion in 10 L of sterile water of 5 ~ 20 ℃ to prepare a suspension containing the DHA solution microencapsulated with a polysaccharide material, the microcapsule solution Kimchi The final product was added to the product, but the microencapsulated DHA was adjusted to a concentration of 1 to 1,000 mg% (w / w).
실시예 2Example 2
상기 실시예 1에서 멸균수를 0.05%(w/v) 글리세롤모노리신올레산(glycerol monoricinoleate) 수용액으로 대체시킨 것을 제외하고는 동일하게 실시하여 다당류물질로 미세캡슐화된 DHA가 첨가된 김치제품을 제조하였다.Except for replacing the sterile water in 0.05% (w / v) glycerol monoricinoleate aqueous solution in Example 1 to prepare a kimchi product added DHA microencapsulated with a polysaccharide material .
실시예 3Example 3
찹쌀전분이 0.5%(w/v)의 농도로 분산되어 있는 수용액내에 친수성 유화제인 트윈 20(tween 20)을 2%(w/v)되게 첨가하여 전체 수용액을 가열살균한 후, 40 ∼ 50℃로 유지되는 항온실에서 보관한 다음, 상기 수용액 500 g에 EPA(eicosapentaenoic acid) 용액 500 g을 첨가시킨 후, 혼합기를 사용하여 균질의 유화액을 제조한 다음, 상기 유화액을 5 ∼ 20℃의 멸균수 10 L에 직접 고압분무시켜 다당류물질로 미세캡슐화된 EPA용액을 함유한 현탁액을 제조하고, 상기 미세캡슐 용액을 김치제품에 첨가하되 미세캡슐화된 EPA가 1 ~ 1000 mg%(w/w)의 농도가 되도록 조절하여 최종제품을 완성하였다.After adding the hydrophilic emulsifier tween 20 to 2% (w / v) in an aqueous solution in which glutinous rice starch is dispersed at a concentration of 0.5% (w / v), the entire aqueous solution is sterilized by heat and then 40 to 50 ° C. After storing in a constant temperature room maintained with, after adding 500 g of the EPA (eicosapentaenoic acid) solution to 500 g of the aqueous solution, using a mixer to prepare a homogeneous emulsion, and then the emulsion is sterilized water of 5 ~ 20 ℃ High-pressure spraying directly to 10 L to prepare a suspension containing the EPA solution microencapsulated with a polysaccharide material, the microcapsule solution was added to the kimchi product concentration of 1 ~ 1000 mg% (w / w) microencapsulated EPA Adjusted to complete the final product.
상기 실시예 1에서 다당류물질로 미세캡슐화된 DHA가 200 mg%(w/v)의 농도로 첨가하여 제조한 김치제품을 일반인 18명(20대 남자 3명, 20대 여자 3명, 30대 남자 3명, 30대 여자 3명, 40대 남자 3명, 40대 여자 3명: 1주일간 관능평가 교육을 미리 실시하였음)에게 관능평가를 실시한 결과, 하기 [표 1]에서와 같이 전원이 미세캡슐화된 DHA가 첨가된 김치와 일반 김치를 구분할 수 없었으며, 미세캡슐화된 DHA 첨가 김치에서의 이미·이취를 심하게 감지하는 사람도 역시 없었다. 따라서, 다당류로 미세캡슐화된 DHA가 첨가된 김치제품은 특별한 이미·이취를 부여하지 않는 것으로 판명되었다.Kimchi product prepared by adding the DHA microencapsulated with a polysaccharide material in Example 1 at a concentration of 200 mg% (w / v) 18 people (3 men in 20s, 3 women in 20s, 30 men) Three, three women in their thirties, three men in their 40s, three women in their 40s: sensory evaluation training was conducted for 1 week in advance), and as a result, all of them were microencapsulated as shown in Table 1 below. It was not possible to distinguish between Kimchi supplemented with DHA and regular Kimchi, and no one was seriously aware of odor and smell in microencapsulated DHA added Kimchi. Therefore, it was found that kimchi products added with DHA microencapsulated with polysaccharides did not impart a special smell and smell.
또, 상기한 동일한 방법에 의하여 제조한 미세캡슐화된 DHA 첨가 김치를 5, 10, 15℃ 및 20℃에서 1개월간 저장하면서 파괴된 미세캡슐을 정량분석한 결과, 하기 [표 2]에서와 같이 5℃ 및 10℃에서는 1개월 동안 미세캡슐이 매우 안정하여 전혀 파괴되지 않았으며, 20℃에서 김치제품을 저장할 경우 30%의 미세캡슐이 파괴되고 70%는 안정한 상태로 유지됨을 확인하였다.In addition, the microencapsulated DHA-added kimchi prepared by the same method described above quantitatively analyzed the broken microcapsules stored for 1 month at 5, 10, 15 ℃ and 20 ℃, as shown in Table 2 below At 1 ° C and 10 ° C, the microcapsules were very stable for 1 month and were not destroyed at all. When the kimchi product was stored at 20 ° C, 30% of the microcapsules were destroyed and 70% were maintained in a stable state.
그리고, 상기한 방법에 의하여 제조한 미세캡슐화된 DHA가 함유된 김치를 고콜레스테롤 환자 30명(20대 남자 5명, 20대 여자 5명, 30대 남자 5명, 30대 여자 5명, 40대 남자 5명, 40대 여자 5명)에게 매식 100 g씩 15일간 투여한 다음 혈액을 채취하여 혈중콜레스테롤 함량을 측정한 결과, 하기 [표 3]의 (2)와 같이 혈액 1 dL내에 약 208 mg의 농도로 존재함을 확인하였으며, 반면에 캡슐화되지 않은 DHA를 동일한 농도로 첨가한 김치를 동일한 방법에 의하여 투입시킨 후 비교 실험한 결과 콜레스테롤이 하기 [표 3]의 (1)과 같이 혈액 1 dL당 평균 255 mg의 농도로 존재함을 확인하였다.In addition, the kimchi containing the microencapsulated DHA prepared by the above-described method, 30 patients with high cholesterol (5 males in their 20s, 5 females in their 20s, 5 males in their 30s, 5 females in their 30s and 40s) 5 males, 5 females in their 40s) were administered 100 g each for 15 days, and blood was collected to measure blood cholesterol content. As shown in (2) of [Table 3], about 208 mg in blood 1 dL It was confirmed that it exists in the concentration of, on the other hand, the kimchi was added by the same method to add unencapsulated DHA in the same concentration and the result of the comparative experiments cholesterol 1 dL as shown in (1) of Table 3 below An average of 255 mg per sugar was confirmed.
이상 설명한 바와 같이 본 발명은 다당류물질로 미세캡슐화된 ω계 고도불포화 지방산 함유 현탁액이 첨가된 이미·이취가 없는 신규한 김치를 제공하는 효과가 있다. 또한 본 발명은 김치내에서 안정성이 있고 시식후에는 혈중콜레스테롤 함량을 저감시킬 수 있는 새로운 형태의 김치제품을 제공하는 효과가 있으므로 발효산업 및 식품의약산업상 매우 유용한 발명인 것이다.As described above, the present invention has an effect of providing a novel kimchi without odor, which has been added a ω-based polyunsaturated fatty acid-containing suspension microencapsulated with a polysaccharide material. In addition, the present invention is a very useful invention in the fermentation industry and food and pharmaceutical industry because it has the effect of providing a new type of kimchi that can be stable in kimchi and reduce blood cholesterol content after tasting.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980053457A KR20000038444A (en) | 1998-12-07 | 1998-12-07 | Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980053457A KR20000038444A (en) | 1998-12-07 | 1998-12-07 | Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20000038444A true KR20000038444A (en) | 2000-07-05 |
Family
ID=19561647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980053457A KR20000038444A (en) | 1998-12-07 | 1998-12-07 | Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20000038444A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020076143A (en) * | 2001-03-26 | 2002-10-09 | 유니레버 엔.브이. | Method for improving the performance of a food product |
KR100758664B1 (en) * | 2006-08-16 | 2007-09-13 | (주)케비젠 | The method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule |
KR20150020513A (en) * | 2013-08-13 | 2015-02-26 | (주)다인내추럴 | Method for Microencapsulation of Fat-Soluble Materials and Method for Functional Beverage by Using Microencapsulated Fat-Soluble Materials |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960007170A (en) * | 1994-08-25 | 1996-03-22 | 최백경 | Foamed mesh manufacturing method and composition used therein |
KR960009858A (en) * | 1994-09-01 | 1996-04-20 | 조광현 | Method for preparing DHA milk with microencapsulated DNA |
KR960020814A (en) * | 1994-12-22 | 1996-07-18 | 이영길 | Docosahexaenoic acid (DHA) -containing functional beverage and preparation method thereof |
KR0144306B1 (en) * | 1994-09-12 | 1998-07-01 | 한일성 | NH-containing Kimchi and its manufacturing method |
-
1998
- 1998-12-07 KR KR1019980053457A patent/KR20000038444A/en active Search and Examination
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR960007170A (en) * | 1994-08-25 | 1996-03-22 | 최백경 | Foamed mesh manufacturing method and composition used therein |
KR960009858A (en) * | 1994-09-01 | 1996-04-20 | 조광현 | Method for preparing DHA milk with microencapsulated DNA |
KR0144306B1 (en) * | 1994-09-12 | 1998-07-01 | 한일성 | NH-containing Kimchi and its manufacturing method |
KR960020814A (en) * | 1994-12-22 | 1996-07-18 | 이영길 | Docosahexaenoic acid (DHA) -containing functional beverage and preparation method thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020076143A (en) * | 2001-03-26 | 2002-10-09 | 유니레버 엔.브이. | Method for improving the performance of a food product |
KR100758664B1 (en) * | 2006-08-16 | 2007-09-13 | (주)케비젠 | The method of preparing a microcapsule containing unsaturated fatty acids, the microcapsule prepared by the method, and articles containing the microcapsule |
KR20150020513A (en) * | 2013-08-13 | 2015-02-26 | (주)다인내추럴 | Method for Microencapsulation of Fat-Soluble Materials and Method for Functional Beverage by Using Microencapsulated Fat-Soluble Materials |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1782807B1 (en) | Jelly composition | |
US7041324B2 (en) | Drinkable omega-3 preparation and storage stabilization | |
DE69935995T2 (en) | POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT | |
US3950547A (en) | Dietary composition and methods of preparing | |
US6444242B1 (en) | Microencapsulated oil or fat product | |
EP1858352B1 (en) | A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base | |
JP2009132684A (en) | Composition and method for body weight management | |
US20070098787A1 (en) | Composition for preventing and treating varicose veins of lower extremities | |
JPH11514221A (en) | New process | |
CN103458856A (en) | Oil-in-water emulsions comprising a polyunsaturated fatty acid and methods of making the same | |
CN102125538A (en) | Novel nutraceutical compositions and use thereof | |
JP4044354B2 (en) | Composition having alcohol resistance, acid resistance and salt resistance and uses | |
EP1108365B1 (en) | Encapsulated long chain alcohols | |
CN107660620A (en) | A kind of sheep base oil grease microcapsule powder and preparation method thereof | |
WO2008059965A1 (en) | Agent for alleviating or preventing stress symptoms and agent for improving mental conditions | |
JPH0424979B2 (en) | ||
EP3287013B1 (en) | Gel composition and method for manufacturing the same | |
KR970705988A (en) | (Preventive or remedy for diseases caused by abnormality of cartilaginous tissues caused by abnormalities in cartilage tissues) | |
KR20000038444A (en) | Preparation method of kimchi added ω -3 polyunsaturated fatty acid(pufa) capsuled with polysaccharides | |
JPH06169735A (en) | Nutritious drink composition | |
CA3135250C (en) | Stable emulsified vitamin and omega fatty acid compositions and process for preparing same | |
WO2010073642A1 (en) | Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent | |
JPH10179086A (en) | Oil-solubilizing liquid containing plant sterol as well as drinks and their production | |
RU2716970C1 (en) | Method of producing a biologically active additive with poly-saturated fatty acids | |
KR960007170B1 (en) | Method of unsaturated fattic acid micro capsule with starch |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
B601 | Maintenance of original decision after re-examination before a trial | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20010921 Effective date: 20021031 |
|
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20021204 Effective date: 20030829 |